219 related articles for article (PubMed ID: 8512814)
21. Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenografts.
Middleton MR; Kelly J; Goodger S; Thatcher N; Margison GP
Cancer Chemother Pharmacol; 2000; 45(1):15-20. PubMed ID: 10647496
[TBL] [Abstract][Full Text] [Related]
22. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
Marathi UK; Dolan ME; Erickson LC
Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide.
Reese JS; Davis BM; Liu L; Gerson SL
Clin Cancer Res; 1999 Jan; 5(1):163-9. PubMed ID: 9918215
[TBL] [Abstract][Full Text] [Related]
24. Sensitization of human colon tumour cell lines to carmustine by depletion of O6-alkylguanine-DNA alkyltransferase.
Magull-Seltenreich A; Zeller WJ
J Cancer Res Clin Oncol; 1995; 121(4):225-9. PubMed ID: 7751321
[TBL] [Abstract][Full Text] [Related]
25. Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanine.
Griffin RJ; Arris CE; Bleasdale C; Boyle FT; Calvert AH; Curtin NJ; Dalby C; Kanugula S; Lembicz NK; Newell DR; Pegg AE; Golding BT
J Med Chem; 2000 Nov; 43(22):4071-83. PubMed ID: 11063604
[TBL] [Abstract][Full Text] [Related]
26. Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors.
Ranson M; Middleton MR; Bridgewater J; Lee SM; Dawson M; Jowle D; Halbert G; Waller S; McGrath H; Gumbrell L; McElhinney RS; Donnelly D; McMurry TB; Margison GP
Clin Cancer Res; 2006 Mar; 12(5):1577-84. PubMed ID: 16533784
[TBL] [Abstract][Full Text] [Related]
27. O6-benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrow.
Chinnasamy N; Rafferty JA; Hickson I; Ashby J; Tinwell H; Margison GP; Dexter TM; Fairbairn LJ
Blood; 1997 Mar; 89(5):1566-73. PubMed ID: 9057638
[TBL] [Abstract][Full Text] [Related]
28. Expression in mammalian cells of the Escherichia coli O6 alkylguanine-DNA-alkyltransferase gene ogt reduces the toxicity of alkylnitrosoureas.
Harris LC; Margison GP
Br J Cancer; 1993 Jun; 67(6):1196-202. PubMed ID: 8512805
[TBL] [Abstract][Full Text] [Related]
29. Resistance of the human O6-alkylguanine-DNA alkyltransferase containing arginine at codon 160 to inactivation by O6-benzylguanine.
Edara S; Kanugula S; Goodtzova K; Pegg AE
Cancer Res; 1996 Dec; 56(24):5571-5. PubMed ID: 8971155
[TBL] [Abstract][Full Text] [Related]
30. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
[TBL] [Abstract][Full Text] [Related]
31. DNA interstrand cross-linking and cytotoxicity induced by chloroethylnitrosoureas and cisplatin in human glioma cell lines which vary in cellular concentration of O6-alkylguanine-DNA alkyltransferase.
Beith J; Hartley J; Darling J; Souhami R
Br J Cancer; 1997; 75(4):500-5. PubMed ID: 9052400
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine.
Dolan ME; Pegg AE; Dumenco LL; Moschel RC; Gerson SL
Carcinogenesis; 1991 Dec; 12(12):2305-9. PubMed ID: 1747932
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
Tentori L; Orlando L; Lacal PM; Benincasa E; Faraoni I; Bonmassar E; D'Atri S; Graziani G
Mol Pharmacol; 1997 Aug; 52(2):249-58. PubMed ID: 9271347
[TBL] [Abstract][Full Text] [Related]
34. Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
Dolan ME; Mitchell RB; Mummert C; Moschel RC; Pegg AE
Cancer Res; 1991 Jul; 51(13):3367-72. PubMed ID: 1647266
[TBL] [Abstract][Full Text] [Related]
35. Depletion of O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine in three-dimensional collagen cultures of normal human breast epithelial cells.
Hamdan MA; Guzman RC; Yang J; Beattie C; Mascharack P; Nandi S
Carcinogenesis; 1992 Oct; 13(10):1743-9. PubMed ID: 1423833
[TBL] [Abstract][Full Text] [Related]
36. O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine.
Lee SM; Thatcher N; Margison GP
Cancer Res; 1991 Jan; 51(2):619-23. PubMed ID: 1824685
[TBL] [Abstract][Full Text] [Related]
37. Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1.
Plummer ER; Middleton MR; Jones C; Olsen A; Hickson I; McHugh P; Margison GP; McGown G; Thorncroft M; Watson AJ; Boddy AV; Calvert AH; Harris AL; Newell DR; Curtin NJ
Clin Cancer Res; 2005 May; 11(9):3402-9. PubMed ID: 15867241
[TBL] [Abstract][Full Text] [Related]
38. Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide.
Kokkinakis DM; Bocangel DB; Schold SC; Moschel RC; Pegg AE
Clin Cancer Res; 2001 Feb; 7(2):421-8. PubMed ID: 11234899
[TBL] [Abstract][Full Text] [Related]
39. Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin.
Bobola MS; Tseng SH; Blank A; Berger MS; Silber JR
Clin Cancer Res; 1996 Apr; 2(4):735-41. PubMed ID: 9816224
[TBL] [Abstract][Full Text] [Related]
40. Chemoprotective gene transfer I: transduction of human haemopoietic progenitors with O6-benzylguanine-resistant O6-alkylguanine-DNA alkyltransferase attenuates the toxic effects of O6-alkylating agents in vitro.
Hickson I; Fairbairn LJ; Chinnasamy N; Lashford LS; Thatcher N; Margison GP; Dexter TM; Rafferty JA
Gene Ther; 1998 Jun; 5(6):835-41. PubMed ID: 9747464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]